Health Care Roundup: Market Talk

Jan. 11, 2024 7:44 am ET

The newest Market Talks protecting the Health Care sector. Published solely on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.

1900 GMT – Intuitive Surgical remains to be grappling with a slowdown in demand for bariatric surgical procedures because of the rise of GLP-1 medicines like Ozempic, Chief Executive Gary Guthart tells an viewers on the JPMorgan Healthcare Conference. “The deceleration hasn’t stopped,” he says. “We’re still growing, but it’s decelerating.” What meaning for the longterm outlook for bariatric weight-loss surgical procedures is unclear. Company executives have beforehand mentioned they anticipate the GLP-1-related slowdown to solely be quick time period. Shares rise 10%. (will.feuer@wsj.com; @WillFOIA)

Copyright ©2024 Dow Jones & Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8

Source: wsj.com